Table 2 Antimicrobial resistance of Campylobacter spp. isolated from patients with diarrhea from Tehran, Iran. AMP Ampicillin, OFX ofloxacin, CHL chloramphenicol, CIP ciprofloxacin, CAR carbenicilin, ERY erythromycin, GEN gentamicin, NAL nalidixic acid, NEO neomycin, COL colistin, STR streptomycin, TET tetracycline, CAZ ceftazidime, CTX cefotaxime, IMI imipenem
Isolate | AMP | OFX | CHL | GEN | CIP | TET | NAL | STR | CAR | NEO | ERY | COL | CAZ | CTX | IMI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C. jejuni (n = 34) | 6 (17.6%) | 31 (91.2%) | 3 (8.8%) | 2 (5.8%) | 29 (85.2%) | 12 (35.2%) | 27 (79.4%) | 3 (8.8%) | 16 (47%) | 4 (11.7%) | 4 (11.7%) | 5 (14.7%) | 21 (61.7%) | 19 (55.8%) | 0 |
C. coli (n = 12) | 2 (16.6%) | 7 (58.3%) | 1 (8.3%) | 0 | 6 (50%) | 3 (25%) | 6 (50%) | 1 (8.3%) | 4 (33.3%) | 1 (8.3%) | 1 (8.3%) | 2 (16.6%) | 5 (50%) | 6 (50%) | 0 |
Others (n = 3) | 0 | 0 | 0 | 0 | 1 (33%) | 0 | 1 (33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total (n = 49) | 8 (16.3%) | 38 (77.5%) | 4 (8.1%) | 2 (4%) | 36 (73.4%) | 15 (30.6%) | 34 (69.3%) | 4 (8.1%) | 20 (40.8%) | 5 (10.2%) | 5 (10.2%) | 7 (14.2%) | 26 (53%) | 25 (51%) | 0 |